Comac Medical is pleased to announce our participation in Outsourcing in Clinical Trials Korea 2025, taking place on December 2–3, 2025, in Seoul, South Korea, at the JW Marriott Dongdaemun Square.

Representing Comac Medical at the event will be Christian Buhlmann, Chief Commercial Officer, and Thomas Dent, Business Development Director, who will be engaging with industry leaders, sponsors and CRO partners to explore how our global and Asia-Pacific trial capabilities can support development programs in Korea and beyond.

The conference agenda will feature sessions on key themes such as:

🔹Operational Outsourcing Strategies – optimizing the clinical trial supply chain and partner ecosystem in Korea.

🔹Regional Clinical Trial Innovations – leveraging Korea’s evolving trial infrastructure and local expertise.

🔹Cross-Border Collaboration – enabling sponsors to integrate Korea into broader global development plans.

With this participation, Comac Medical reinforces its commitment to supporting high-quality, efficient clinical research in the Asia-Pacific region, offering end-to-end services that bridge local insight with global standards.

We welcome you to meet with Christian and Thomas to learn more about how Comac Medical can accelerate your clinical trial execution in Korea and beyond.